Welcome Guest | Register / Login

Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Ligand Pharmaceuticals Inc - Key Facts
Ligand Pharmaceuticals Inc - Key Employees
Ligand Pharmaceuticals Inc - Key Employee Biographies
Ligand Pharmaceuticals Inc - Major Products and Services
Ligand Pharmaceuticals Inc - History
Ligand Pharmaceuticals Inc - Company Statement
Ligand Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Ligand Pharmaceuticals Inc - Business Description
Ligand Pharmaceuticals Inc - Corporate Strategy
Ligand Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Ligand Pharmaceuticals Inc - Strengths
Ligand Pharmaceuticals Inc - Weaknesses
Ligand Pharmaceuticals Inc - Opportunities
Ligand Pharmaceuticals Inc - Threats
Ligand Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company's Lifesciences Financial Deals and Alliances
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Ligand Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company's Recent Developments
May 06, 2020: Ligand reports first quarter 2020 financial results
Apr 06, 2020: Ligand provides a corporate update and announces May 6th as the date for first quarter earnings call
Mar 10, 2020: Ligand's presentation at the Barclays Global Healthcare Conference now a webcast only, new slides available on Ligand.com
Feb 27, 2020: Ligand raises 2020 financial guidance due to higher captisol material sales
Feb 06, 2020: Ligand reports fourth quarter and full year 2019 financial results
Feb 03, 2020: Ligand's technologies support and enable potential Coronavirus treatments
Nov 05, 2019: Ligand reports third quarter 2019 financial results
Oct 15, 2019: Ligand appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
Jul 30, 2019: Ligand Reports Second Quarter 2019 Financial Results
May 02, 2019: Ligand reports first quarter 2019 financial results
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Ligand Pharmaceuticals Inc, Key Facts
Ligand Pharmaceuticals Inc, Key Employees
Ligand Pharmaceuticals Inc, Key Employee Biographies
Ligand Pharmaceuticals Inc, Major Products and Services
Ligand Pharmaceuticals Inc, History
Ligand Pharmaceuticals Inc, Subsidiaries
Ligand Pharmaceuticals Inc, Key Competitors
Ligand Pharmaceuticals Inc, Ratios based on current share price
Ligand Pharmaceuticals Inc, Annual Ratios
Ligand Pharmaceuticals Inc, Annual Ratios (Cont...1)
Ligand Pharmaceuticals Inc, Annual Ratios (Cont...2)
Ligand Pharmaceuticals Inc, Interim Ratios
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Ligand Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Ligand Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Ligand Pharmaceuticals Inc, Ratio Charts
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy